DCs Pulsed with Novel HLA-A2-Restricted CTL Epitopes against Hepatitis C Virus Induced a Broadly Reactive Anti-HCV-Specific T Lymphocyte Response

被引:13
作者
Guo, Zhongsheng [1 ,2 ]
Zhang, Henghui [1 ,2 ]
Rao, Huiying [1 ,2 ]
Jiang, Dong [1 ,2 ]
Cong, Xu [1 ,2 ]
Feng, Bo [1 ,2 ]
Wang, Jianghua [1 ,2 ]
Wei, Lai [1 ,2 ]
Chen, Hongsong [1 ,2 ]
机构
[1] Peking Univ, Inst Hepatol, Peoples Hosp, Beijing 100871, Peoples R China
[2] Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing, Peoples R China
关键词
DENDRITIC CELLS; THERAPEUTIC VACCINATION; IMMUNE-RESPONSES; INFECTION; CYTOKINES; IDENTIFICATION; DETERMINANTS; DYSFUNCTION; MATURATION; CD4(+);
D O I
10.1371/journal.pone.0038390
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: To determine the capacity of dendritic cells (DCs) loaded with single or multiple-peptide mixtures of novel hepatitis C virus (HCV) epitopes to stimulate HCV-specific cytotoxic T lymphocyte (CTL) effector functions. Methods: A bioinformatics approach was used to predict HLA-A2-restricted HCV-specific CTL epitopes, and the predicted peptides identified from this screen were synthesized. Subsequent IFN-gamma ELISPOT analysis detected the stimulating function of these peptides in peripheral blood mononuclear cells (PBMCs) from both chronic and self-limited HCV infected subjects (subjects exhibiting spontaneous HCV clearance). Mature DCs, derived in vitro from CD14(+) monocytes harvested from the study subjects by incubation with appropriate cytokine cocktails, were loaded with novel peptide or epitope peptide mixtures and co-cultured with autologous T lymphocytes. Granzyme B (GrB) and IFN-gamma ELISPOT analysis was used to test for epitope-specific CTL responses. T-cell-derived cytokines contained in the co-cultured supernatant were detected by flow cytometry. Results: We identified 7 novel HLA-A2-restricted HCV-specific CTL epitopes that increased the frequency of IFN-gamma-producing T cells compared to other epitopes, as assayed by measuring spot forming cells (SFCs). Two epitopes had the strongest stimulating capability in the self-limited subjects, one found in the E2 and one in the NS2 region of HCV; five epitopes had a strong stimulating capacity in both chronic and self-limited HCV infection, but were stronger in the self-limited subjects. They were distributed in E2, NS2, NS3, NS4, and NS5 regions of HCV, respectively. We also found that mDCs loaded with novel peptide mixtures could significantly increase GrB and IFN-gamma SFCs as compared to single peptides, especially in chronic HCV infection subjects. Additionally, we found that DCs pulsed with multiple epitope peptide mixtures induced a Th1-biased immune response. Conclusions: Seven novel and strongly stimulating HLA-A2-restricted HCV-specific CTL epitopes were identified. Furthermore, DCs loaded with multiple-epitope peptide mixtures induced epitope-specific CTLs responses.
引用
收藏
页数:10
相关论文
共 51 条
[1]   Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial [J].
Alvarez-Lajonchere, L. ;
Shoukry, N. H. ;
Gra, B. ;
Amador-Canizares, Y. ;
Helle, F. ;
Bedard, N. ;
Guerra, I. ;
Drouin, C. ;
Dubuisson, J. ;
Gonzalez-Horta, E. E. ;
Martinez, G. ;
Marante, J. ;
Cinza, Z. ;
Castellanos, M. ;
Duenas-Carrera, S. .
JOURNAL OF VIRAL HEPATITIS, 2009, 16 (03) :156-167
[2]   Differential dysfunction in dendritic cell subsets during chronic HCV infection [J].
Averill, Lynn ;
Lee, William M. ;
Karandikar, Nitin J. .
CLINICAL IMMUNOLOGY, 2007, 123 (01) :40-49
[3]   Prediction of CTL epitopes using QM, SVM and ANN techniques [J].
Bhasin, M ;
Raghava, GPS .
VACCINE, 2004, 22 (23-24) :3195-3204
[4]  
Bi SL, 1993, COMPLETE HEPATITIS C
[5]   Adaptive immune responses in acute and chronic hepatitis C virus infection [J].
Bowen, DG ;
Walker, CM .
NATURE, 2005, 436 (7053) :946-952
[6]  
Cacciarelli TV, 1996, HEPATOLOGY, V24, P6, DOI 10.1053/jhep.1996.v24.pm0008707283
[7]   Identifying structure-function relationships in four-helix bundle cytokines: Towards de novo mimetics design [J].
Chaiken, IM ;
Williams, WV .
TRENDS IN BIOTECHNOLOGY, 1996, 14 (10) :369-375
[8]   PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine [J].
Cheever, Martin A. ;
Higano, Celestia S. .
CLINICAL CANCER RESEARCH, 2011, 17 (11) :3520-3526
[9]   Comprehensive analyses of CD8+T cell responses during longitudinal study of acute human hepatitis C [J].
Cox, AL ;
Mosbruger, T ;
Lauer, GM ;
Pardoll, D ;
Thomas, DL ;
Ray, SC .
HEPATOLOGY, 2005, 42 (01) :104-112
[10]   Dendritic cells in hepatitis C infection: can they (help) win the battle? [J].
Dolganiuc, Angela ;
Szabo, Gyongyi .
JOURNAL OF GASTROENTEROLOGY, 2011, 46 (04) :432-447